For clinicians, these results emphasize the importance of timely initiation of GLP-1 receptor agonists after acute events as part of standard secondary prevention, irrespective of glycemic control, aligning with guidelines that prioritize cardiovascular protection as a treatment goal
By mimicking the effects of a naturally occurring hormone, Semaglutide and Tirzepatide help regulate appetite, control blood sugar levels, and enhance feelings of fullness
In this context, GLP-1 receptor agonists have been linked to improved mental health outcomes, including improvements in depression and anxiety (as measured by standardized scales such as the Hamilton Depression Rating Scale 10 and Beck Depression Inventory) 11 and improvements in quality of life (as measured by standardized scales such as the Psychological General Well-Being Index 12 and Global Assessment of Functioning)
doi:10.2174/157340607780620662 Winther KH, Wichman JE, Bonnema SJ, Hegeds L
